Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are: To determine the maximum tolerated dose of Gemcitabine and
Platinol followed by Pemetrexed and Gemcitabine in patients with advanced or metastatic
transitional cell carcinoma of the urothelium; To determine the safety of Gemcitabine and
Platinol followed by Pemetrexed and Gemcitabine and any side effects that might be associated
with the combination of these drugs; To determine whether Gemcitabine and Platinol followed
by Pemetrexed and Gemcitabine can help patients with advanced bladder cancer live longer; To
determine whether Gemcitabine and Platinol followed by Pemetrexed and Gemcitabine can make
your tumor smaller or disappear, and for how long.